Status:

ACTIVE_NOT_RECRUITING

Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms

Lead Sponsor:

Imperial College London

Collaborating Sponsors:

Wellcome Trust

Conditions:

Prostate Cancer

Metastatic Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE2

Brief Summary

Local cytoreductive treatments for men with newly diagnosed metastatic prostate cancer in addition to standard of care treatment

Detailed Description

TITLE: Additional Treatments to the Local tumour for metastatic prostate cancer: Assessment of Novel Treatment Algorithms (ATLANTA) OBJECTIVES: To determine whether the addition of local treatment to...

Eligibility Criteria

Inclusion

  • Diagnosed with prostate cancer within 6 months of screening visit
  • Metastatic disease (Any T, Any N, M1+) of any grade, stage or Prostate Specific Antigen (PSA) level.
  • Fit to undergo standard of care treatment for metastatic disease and both minimally invasive therapy and prostate radiotherapy/prostatectomy.
  • Performance status 0-2
  • Histologically proven local tumour

Exclusion

  • Patient did not undergo and/or is unable to undergo standard of care baseline imaging tests for confirmation of metastatic status (CT abdomen/pelvis AND chest Xray (or CT chest) AND radioisotope bone scan (or whole body imaging such as MRI or PET imaging as alternative to all preceding scans mentioned here) AND prostate MRI.
  • Prior exposure to long-term androgen deprivation therapy or hormonal therapy for the treatment of prostate cancer unless started within 6 months of screening visit.
  • Prior chemotherapy or local or systemic therapy for treatment of prostate cancer (apart from ADT or hormonal therapy as outlined above)

Key Trial Info

Start Date :

April 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2027

Estimated Enrollment :

433 Patients enrolled

Trial Details

Trial ID

NCT03763253

Start Date

April 10 2019

End Date

January 31 2027

Last Update

February 7 2025

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

Wirral University Teaching Hospital, Wirral University Teaching Hospital NHS Foundation Trust

Birkenhead, United Kingdom, CH49 5PE

2

Glan Clwyd Hospital

Bodelwyddan, United Kingdom, LL18 5UJ

3

Darent Valley Hospital

Dartford, United Kingdom

4

Royal Devon and Exeter NHS Trust

Exeter, United Kingdom, EX2 5DW